The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Modi stressed the need to ensure that the entire Covid infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes, and human resources
Allam was serving recently as the CEO at Public Investment Fund
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
Post the sale, Patel family has become the single largest promoter shareholder in the company
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated
